Allergic rhinitis in Adult
First-line treatments include pharmacotherapy and allergen avoidance.
A 2017 Joint Task Force of the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology provided the following "strong recommendations":
- For initial treatment of seasonal allergic rhinitis in persons aged 12 years or older, routinely prescribe monotherapy with an intranasal corticosteroid rather than an intranasal corticosteroid in combination with an oral antihistamine.
- For initial treatment of seasonal allergic rhinitis in persons aged 15 years or older, recommend an intranasal corticosteroid over a leukotriene receptor antagonist.
J30.9 – Allergic rhinitis, unspecified
61582004 – Allergic Rhinitis
- Vasomotor rhinitis
- Drug-induced rhinitis (rebound from decongestant use, cocaine, oral contraceptives, nonsteroidal anti-inflammatory drugs [NSAIDs], chlorpromazine)
- Nasal polyps
- Nasal tumor (eg, nasopharyngeal cancer)
- Granulomatous disease
- Foreign body
- Deviated septum
- Choanal atresia in infants
- Adenoid hypertrophy in children